William K Daniel

Director William K Daniel purchases 10,000 shares as stock trades well below its 52-week high; repeat buyer with proven timing.

William K Daniel, a director of Henry Schein, purchased shares while the stock trades substantially below its 52-week high, extending a pattern of deliberate accumulation he established earlier in the prior year. His previous open-market purchase resulted in meaningful gains over both near and longer-term periods, and the stock has now pulled back further from those levels—Daniel is buying into additional weakness. The company itself remains solidly profitable with strong revenue growth, giving the director a financially healthy business to buy into rather than a turnaround play. This is Daniel's second open-market purchase in the 36-month window, indicating a consistent orientation toward accumulating shares at depressed valuations rather than selling, which aligns with his track record of well-timed prior purchases.

Director Daniel William K purchases 10,000 shares of HSIC at $67.08; stock down -19.3% from 52-week high of $81.91

Director Daniel William K purchased 10,000 shares at $67.08 on 2025-08-07, establishing a new 10,000 share position with no prior holdings. The purchase occurs at a price that is -19.3% below the 52-week high of $81.91 and reflects a -10.0% decline over the past 30 days. HSIC trades at a P/E of 20.59 with recent quarterly revenue of $3.2B and annual revenue growth of +2.7%, indicating a moderately valued healthcare distributor in a modest growth phase. The director's acquisition represents a material commitment of capital (total value $670.8K) in a depressed price environment relative to recent highs, though without prior transaction history at this ticker we cannot establish whether this reflects a systematic pattern or isolated activity.